Free tool
FAERS Monitor: Avastin
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 125085 or its brand name (Avastin, Bevacizumab). Reports on generic versions are filed under their own applications.
Reports
125,237
Serious
114,342
91% of reports
Hospitalization
40,518
Death reported
28,436
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use14,881
- death13,302
- diarrhoea7,457
- disease progression7,448
- fatigue6,622
- nausea6,613
- hypertension5,933
- vomiting5,030
- anaemia4,505
- pyrexia4,134
- neutropenia4,092
- asthenia3,624
- decreased appetite3,521
- dyspnoea3,465
- thrombocytopenia3,452
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 638 |
| 2005 | 1,129 |
| 2006 | 1,709 |
| 2007 | 2,188 |
| 2008 | 3,135 |
| 2009 | 3,354 |
| 2010 | 3,388 |
| 2011 | 3,446 |
| 2012 | 9,608 |
| 2013 | 5,546 |
| 2014 | 4,774 |
| 2015 | 4,948 |
| 2016 | 5,149 |
| 2017 | 7,561 |
| 2018 | 7,178 |
| 2019 | 6,405 |
| 2020 | 6,492 |
| 2021 | 7,914 |
| 2022 | 8,089 |
| 2023 | 8,847 |
| 2024 | 8,482 |
| 2025 | 8,818 |
| 2026 | 6,439 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,928,922 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| disease progressionSignal | 7,448 | 11.2 | 11.0 | 65,288 |
| thrombocytopeniaSignal | 3,452 | 5.3 | 5.1 | 11,787 |
| neutropeniaSignal | 4,092 | 5.2 | 5.0 | 13,471 |
| hypertensionSignal | 5,933 | 4.8 | 4.7 | 17,585 |
| anaemiaSignal | 4,505 | 4.0 | 3.9 | 10,146 |
| off label useSignal | 14,881 | 2.9 | 2.8 | 18,813 |
| deathSignal | 13,302 | 2.6 | 2.6 | 13,655 |
| decreased appetiteSignal | 3,521 | 2.6 | 2.5 | 3,361 |
| pyrexiaSignal | 4,134 | 2.0 | 2.0 | 2,134 |
| diarrhoea | 7,457 | 2.0 | 1.9 | 3,525 |
| vomiting | 5,030 | 1.8 | 1.8 | 1,828 |
| asthenia | 3,624 | 1.6 | 1.6 | 877 |
| fatigue | 6,622 | 1.4 | 1.4 | 889 |
| nausea | 6,613 | 1.4 | 1.4 | 801 |
| dyspnoea | 3,465 | 1.0 | 1.0 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.